Labetalol tablet nonclinical toxicology: Difference between revisions

Latest revision as of 20:30, 21 July 2014

Redirect to:

@@ Line 1: / Line 1: @@
-__NOTOC__
+#REDIRECT [[Labetalol#Nonclinical Toxicology]]
-{{Labetalol}}
-{{CMG}}; {{AE}} {{SS}}
-==Nonclinical Toxicology==
-Long-term oral dosing studies with labetalol HCl for 18 months in mice and for 2 years in rats showed no evidence of carcinogenesis. Studies with labetalol HCl using dominant lethal assays in rats and mice and exposing microorganisms according to modified Ames tests showed no evidence of mutagenesis.<ref name="dailymed.nlm.nih.gov">{{Cite web  | last =  | first =  | title = LABETALOL HYDROCHLORIDE TABLET, FILM COATED [WATSON LABORATORIES, INC.] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a5b65a9b-6b8a-48a4-9c72-0e605bb309eb | publisher =  | date =  | accessdate = 5 February 2014 }}</ref>
-==References==
-{{Reflist|2}}
 [[Category:Beta blockers]]
@@ Line 17: / Line 5: @@
 [[Category:Cardiovascular Drugs]]
 [[Category:Drugs]]
-{{WikiDoc Help Menu}}
-{{WikiDoc Sources}}